Ground-breaking new Curtin University-led research has discovered a possible new pathway that may kickstart Alzheimer’s disease, in a significant finding that offers potential new prevention and treatment opportunities for Australia’s second-leading cause of death. The study, published in the prestigious PLOS Biology journal and tested on mouse models , […]
Category: Alzheimer’s Disease
90% of Patients With Alzheimer’s Disease Would Not Have Qualified for Aducanumab Trials
In June 2021, the Food & Drug Administration (FDA) granted accelerated approval for aducanumab to treat patients with mild cognitive impairment or mild dementia due to Alzheimer’s disease. The two phase-3 clinical trials of aducanumab on which the drug’s approval was based showed increased risk of certain adverse vascular […]
Emerging Peer-Reviewed Study Shows Reversal in Biological Hallmarks Responsible for Development of Alzheimer’s Disease
TEL AVIV, Israel, Sept. 9, 2021 /PRNewswire/ — A new study, published today in peer-review medical journal Aging , marks the first time non-pharmaceutical clinical exploration proves efficacy in reversing the main activators of Alzheimer’s disease. Continue Reading Study results show elevated blood flow and improved oxygenation in the […]
Emerging Peer-Reviewed Study Shows Reversal in Biological Hallmarks Responsible for Development of Alzheimer’s Disease
Hyperbaric Oxygen Therapy (HBOT) Holds Promise for New Approach to Alzheimer’s by Targeting the Core Pathology/Biology Responsible for the Development of the Disease TEL AVIV, Israel, Sept. 9, 2021 /PRNewswire/ — A new study, published today in peer-review medical journal Aging , marks the first time non-pharmaceutical clinical exploration […]
Dementia Research Often Lacks Race Data
Click here to view original web page at Dementia Research Often Lacks Race Data
Recent research about Alzheimer’s disease and dementia has significant limitations that affect its generalizability, a systematic review showed. Only one in five studies reported on ethnicity or race, and those that did had almost exclusively white participants, reported Frank Wolters, MD, PhD, of Erasmus University Medical Center in Rotterdam, […]
Stable memory test scores for Alzheimer’s patients with omega-3 intake
Credit: CC0 Public Domain A unique study on Alzheimer’s disease examines the effect of omega-3 fatty acids with memory tests and testing of spinal fluid. “This study is unique. It is the first ever to collect data on these new biomarkers in people with Alzheimer’s disease treated with omega-3 […]
Study examines the effect of omega-3 fatty acids in people with Alzheimer’s disease
A study on Alzheimer’s disease examines the effect of omega-3 fatty acids – with memory tests and testing of spinal fluid. This study is unique. It is the first ever to collect data on these new biomarkers in people with Alzheimer’s disease treated with omega-3 fatty acids.” Yvonne Freund-Levi, […]
Diadem Announces Publication of Clinical Data Showing Its AlzoSure® Biomarker Test Accurately Predicts Progression to Alzheimer’s Disease Six Years Before Diagnosis
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here . MILAN, Aug. 26, 2021 /PRNewswire/ — Diadem srl, a company developing the first blood-based test for the early prediction of progression to Alzheimer’s disease (AD), today announced results from a […]
Diadem Announces Publication of Clinical Data Showing Its AlzoSure® Biomarker Test Accurately Predicts Progression to Alzheimer’s Disease Six Years Before Diagnosis
MILAN, Aug. 26, 2021 /PRNewswire/ — Diadem srl, a company developing the first blood-based test for the early prediction of progression to Alzheimer’s disease (AD), today announced results from a retrospective longitudinal study of its AlzoSure ® Predict prognostic biomarker test. The study, A conformational variant of p53 (U-p53 […]
Diadem Announces Publication of Clinical Data Showing Its AlzoSure® Biomarker Test Accurately Predicts Progression to Alzheimer’s Disease Six Years Before Diagnosis
Cision –AlzoSure® Predict Identifies Individuals Who Will Progress to Alzheimer’s Disease (AD) Up to Six Years Before Diagnosis with High Accuracy (AUC=.99) Using Simple Blood Draw– –Prognostic Performance for Progression to Alzheimer’s Significantly Better than Conventional PET Amyloid Imaging (P<0.001)-- --As a Simple, Accessible Accurate Prognostic Blood Test for [...]